Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMID 9409562)

Published in Am J Respir Cell Mol Biol on December 01, 1997

Authors

M M Höper1, N F Voelkel, T O Bates, J D Allard, M Horan, D Shepherd, R M Tuder

Author Affiliations

1: Department of Pathology, Pulmonary Hypertension Center, and University of Colorado Health Sciences Center, Denver 80262, USA.

Articles citing this

Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest (2000) 3.03

Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med (2003) 1.69

Is cyclooxygenase-2 the alpha and the omega in cancer? J Clin Invest (2000) 1.22

Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J Exp Med (2002) 1.08

Enhancement by histamine of vascular endothelial growth factor production in granulation tissue via H(2) receptors. Br J Pharmacol (2001) 1.03

PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis. FASEB J (2009) 1.02

Role of cytosolic phospholipase A(2) in retinal neovascularization. Invest Ophthalmol Vis Sci (2009) 1.00

Genetic deletion of COX-2 diminishes VEGF production in mouse retinal Müller cells. Exp Eye Res (2010) 0.99

The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice. BMC Cancer (2006) 0.97

Angiogenesis in nodal B cell lymphomas: a high throughput study. J Clin Pathol (2006) 0.95

Involvement of COX-2/PGE2 signalling in hypoxia-induced angiogenic response in endothelial cells. J Cell Mol Med (2012) 0.92

Crosstalk of oncogenic and prostanoid signaling pathways. J Cancer Res Clin Oncol (2004) 0.92

ERK1/2/COX-2/PGE2 signaling pathway mediates GPR91-dependent VEGF release in streptozotocin-induced diabetes. Mol Vis (2014) 0.87

The MAPK signaling pathway mediates the GPR91-dependent release of VEGF from RGC-5 cells. Int J Mol Med (2015) 0.83

The hexane fraction of Ardisia crispa Thunb. A. DC. roots inhibits inflammation-induced angiogenesis. BMC Complement Altern Med (2013) 0.82

A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors. Mol Cancer Ther (2008) 0.78

JTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in rats. BMC Cancer (2005) 0.77

A retrospective comparison of inhaled milrinone and iloprost in post-bypass pulmonary hypertension. Heart Vessels (2017) 0.75

Articles by these authors

Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest (2000) 5.26

Genome-wide association studies establish that human intelligence is highly heritable and polygenic. Mol Psychiatry (2011) 4.16

Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med (2001) 3.92

Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol (1994) 3.83

Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res (2000) 3.60

Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci U S A (2000) 3.47

Steady-state concentrations of coenzyme A, acetyl-coenzyme A and long-chain fatty acyl-coenzyme A in rat-liver mitochondria oxidizing palmitate. Biochem J (1965) 3.43

Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J (2001) 3.20

Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity (2001) 3.18

Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol (2004) 2.93

Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J (2005) 2.82

Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol (2000) 2.73

Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest (1998) 2.54

Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest (1998) 2.37

Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest (1995) 2.30

Daughter of sevenless is a substrate of the phosphotyrosine phosphatase Corkscrew and functions during sevenless signaling. Cell (1996) 2.30

Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest (1997) 2.29

Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol (2001) 2.24

Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med (1999) 2.21

Capgras syndrome: possibly more common among the Maori of New Zealand. Aust N Z J Psychiatry (2000) 2.02

Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis. Circ Res (2001) 2.00

Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest (1987) 1.96

The kinetic properties of citrate synthase from rat liver mitochondria. Biochem J (1969) 1.86

Synaptic desensitization of NMDA receptors by calcineurin. Science (1995) 1.86

GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol Psychiatry (2004) 1.79

Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res (2001) 1.75

A comparison of individual and population smoking data from a postal survey and general practice records. Br J Gen Pract (2000) 1.73

Factors related to maternal employment status following the premature birth of an infant. Nurs Res (1990) 1.67

Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol (1999) 1.63

Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis (1990) 1.62

Hypoxia inducible factor-1α in human emphysema lung tissue. Eur Respir J (2010) 1.62

Proactive integrated care improves quality of life in patients with COPD. Eur Respir J (2009) 1.61

Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. J Clin Invest (1999) 1.59

Psychiatric care in general practice: an experiment in collaboration. Br Med J (1966) 1.58

Nonimmunological production of leukotrienes induced by platelet-activating factor. Science (1982) 1.58

Primary pulmonary hypertension between inflammation and cancer. Chest (1998) 1.57

In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol (1998) 1.54

A continuous recording technique for the measurement of carbon dioxide, and its application to mitochondrial oxidation and decarboxylation reactions. Biochem J (1967) 1.53

Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med (1996) 1.53

Common SNPs explain some of the variation in the personality dimensions of neuroticism and extraversion. Transl Psychiatry (2012) 1.52

Agarose infiltration improves morphology of cryostat sections of lung. Lab Invest (1994) 1.51

Hypothyroidism and primary pulmonary hypertension: an autoimmune pathogenetic link? Ann Intern Med (1993) 1.51

Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly. Genes Brain Behav (2007) 1.47

Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. Science (1987) 1.47

Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol (1997) 1.46

Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia. J Appl Physiol (1985) (2001) 1.44

Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300 m. J Appl Physiol (1985) (1987) 1.40

Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis. Br J Dermatol (2005) 1.40

Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int Immunol (2001) 1.40

Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest (2000) 1.39

A necessary neologism: the origin and uses of suicide. Suicide Life Threat Behav (1994) 1.39

Analysis of Escherichia coli TonB membrane topology by use of PhoA fusions. J Bacteriol (1991) 1.36

Mature dendritic cells prime functionally superior melan-A-specific CD8+ lymphocytes as compared with nonprofessional APC. J Immunol (2001) 1.34

ATP controlled acetoacetate and citrate synthesis by rat liver mitochondria oxidising palmitoyl-carnitine, and the inhibition of citrate synthase by ATP. Biochem Biophys Res Commun (1966) 1.31

HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. Am J Pathol (2001) 1.29

Apoptosis in the lung: induction, clearance and detection. Am J Physiol Lung Cell Mol Physiol (2008) 1.29

The pathobiology of pulmonary hypertension. Endothelium. Clin Chest Med (2001) 1.27

HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism. Thorax (2008) 1.26

Maternal employment, family functioning, and preterm infant development at 9 and 12 months. Res Nurs Health (1993) 1.25

Pulmonary hypertension and inflammation. J Lab Clin Med (1998) 1.25

Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats. J Clin Invest (1996) 1.25

The pressure-overloaded right ventricle in pulmonary hypertension. Chest (1998) 1.24

Monocyte responses to sulfatide from Mycobacterium tuberculosis: inhibition of priming for enhanced release of superoxide, associated with increased secretion of interleukin-1 and tumor necrosis factor alpha, and altered protein phosphorylation. Infect Immun (1991) 1.23

Do newspaper reports of coroners' inquests incite people to commit suicide? Br J Psychiatry (1977) 1.23

Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia. J Immunol (1998) 1.21

Metabolic development and secondary biosynthesis in Penicillium urticae. Can J Microbiol (1965) 1.21

Up-regulation of elastase in acute wounds of healthy aged humans and chronic venous leg ulcers are associated with matrix degradation. Lab Invest (1997) 1.20

Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. Am J Respir Cell Mol Biol (1994) 1.18

5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension. Am J Respir Crit Care Med (1998) 1.18

Maternal employment effects on family and preterm infants at three months. Nurs Res (1991) 1.18

A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response. J Immunol (2000) 1.18

Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J (1995) 1.17

Neuronal growth factor regulation of two different sodium channel types through distinct signal transduction pathways. J Cell Biol (1993) 1.16

Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling. Am J Respir Crit Care Med (2001) 1.16

Obliterative bronchiolitis: varying presentations and clinicopathological correlation. Eur Respir J (2002) 1.16

Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. Am Rev Respir Dis (1989) 1.15

Epidemiologic considerations in defining hypertension. Med Clin North Am (1987) 1.15

Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension. N Engl J Med (1983) 1.11

The aftermath of suicide. Br Med J (1974) 1.11

PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats. J Appl Physiol (1985) (1992) 1.10

Chronic intrauterine pulmonary hypertension impairs endothelial nitric oxide synthase in the ovine fetus. Am J Physiol (1997) 1.10

Persistent larval sensory neurons in adult Drosophila melanogaster. J Neurobiol (1999) 1.08

Measurement of peptidoleukotrienes in biological fluids. J Appl Physiol (1985) (1990) 1.08

Cathepsin D exon 2 polymorphism associated with general intelligence in a healthy older population. Mol Psychiatry (2003) 1.08

Vasopressin-induced pulmonary vasodilation in rats. Am J Physiol (1989) 1.07